https://www.selleckchem.com/products/ABT-263.html
However patients with advanced stage disease had higher doses and multiple doses than patients with early stage disease. The rate of hematological malignancy was found to be higher than the general population. 175 mCI doses. Thrombocytopenia and lymphopenia were observed significantly with multiple dose administration. The higher frequency of anemia, thrombocytopenia, leukopenia, neutropenia, and lymphopenia were found in patients with advanced stage disease. However patients with advanced stage disease had higher doses and multiple dos
Like
Comment
Share
